FDA places a hold on Ocugen's plan for U.S. trials of the Covid-19 vaccine Covaxin
November 30, 2021 at 13:06 PM EST
The Malvern firm has a deal that will get it 45% of sales of the Covid-19 vaccine in the United States, if the product gets FDA approval.
